Clinical Trial 49792

Pinellas Park, FL 33782


Summary:

The purpose of this study is to demonstrate that study drug 1 mg once-weekly improves clinical outcomes including walking distance compared to placebo in patients with type 2 diabetes and intermittent claudication due to peripheral arterial disease (PAD).  The study requires 9 visits over the period of 1 year.  The medication is a weekly injection.  Subjects will be required to walk on a treadmill at a very slow pace.  Subjects will be seen by a board-certified physician and the study nurse.  Compenation will be provided for completed visits.




Qualified Participants Must:

• Be at least 18 years of age
• have controlled Type 2 diabetes
• have pain in the calves when walking that stops at rest
• be willing to attend study visits about once per month for the first 3 months and every three months following
• be able and willing to walk on a treadmill
• must not be taking a GLP-1 receptor antagonist such as Victoza


Qualified Participants May Receive:

All Medical evaluations, study treatment or placebo, monitoring throughout the study and compensation for time and travel


Available At:

DMI Research
6699 90th Ave
Pinellas Park, FL 33782
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.